Department of Mining, Metallurgical and Materials Engineering, Universitė Laval, 1065, av. de la Médecine, Québec G1 V 0A6, Canada.
Centre de recherche en infectiologie du CHU de Québec and Department of Microbiology and Immunology, Faculté de Medicine, Université Laval, 2705 Boul. Laurier, Québec G1V4G2, Canada.
ACS Appl Bio Mater. 2024 Jun 17;7(6):4039-4050. doi: 10.1021/acsabm.4c00373. Epub 2024 Jun 3.
We investigated the possibility of loading PMMA bone cement with antimicrobial nanostructured AgNbO particles to counter biofilm formation at the cement-tissue interface. We found that a formulation containing (1-4)% AgNbO showed high antibacterial activity against Gram-positive and Gram-negative while not showing any toxicity against THP1 human cell lines. In addition, loading the particles did not impact the mechanical properties of the cement. The results thus obtained illustrate the potential of the approach to replace the current technique of mixing cement with conventional antibiotics, which is associated with shortcomings such as efficacy loss from antibiotic depletion.
我们研究了将抗菌纳米结构 AgNbO 颗粒负载到 PMMA 骨水泥中以防止水泥-组织界面处生物膜形成的可能性。我们发现,含有(1-4)%AgNbO 的配方对革兰氏阳性菌和革兰氏阴性菌表现出高抗菌活性,而对 THP1 人细胞系没有任何毒性。此外,负载颗粒不会影响水泥的机械性能。因此,该方法具有替代当前将水泥与传统抗生素混合的技术的潜力,目前的技术存在抗生素耗尽导致疗效丧失等缺点。